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Background: Extension of a single incision for the purpose of specimen extraction in single-port laparoscopic
surgery (SPLS) can undermine the merits of SPLS, either by hurting cosmesis or by increasing wound morbidity.
Methods: We retrospectively analyzed the clinical outcomes of patients undergoing SPLS sigmoidectomy, either
with transanal specimen extraction (TASE, n = 15) or transumbilical specimen extraction (TUSE, n = 68), for colorectal
cancer between March 2009 and March 2013. The inclusion criterion was a tumor diameter of ≤ 5 cm. The median
follow-up was 93 months (range 13 – 149).
Results: Most of intraoperative and postoperative variables were comparable between the two groups, except for
lengthening of operation time in TASE (287 ± 87 min vs. 226 ± 78 min, P = 0.011). TUSE did not lengthen the
duration of postoperative recovery, hospital stay, or pain, or increase the incidence of postoperative complications.
Whereas TUSE showed 8.8% (6/68) of wound-related complications, TASE did not show wound-related complications
during follow-up period (P = 0.586).
Conclusion: With the exception of a prolonged operation time, TASE showed equivalent surgical outcomes as TUSE in
SPLS sigmoidectomy. Thus, the implement of TASE is expected to provide one way of reducing wound-related
complications in SPLS in patients with a tumor diameter of ≤5 cm.
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In the era of laparoscopy, pioneering surgeons continue
to attempt to reduce the size and number of incision(s)
in order to maximize the benefits of minimally invasive
surgery. The size and number of incision(s) is important
because these parameters are closely related to the risk
of various postoperative sequelae, such as pain, infection,
injury to the vessels and nerves of the abdominal wall,
and incisional hernia [1-3]. In this respect, the introduc-
tion of single-port laparoscopic surgery (SPLS) has raised
the possibility of overcoming, or at least effectively redu-
cing, wound-related morbidity. SPLS does dramatically
reduce the number of surgical wounds. However, when it
is necessary to extract a bulky specimen, such as the liver,
spleen, or an intestinal segment, a corresponding incision* Correspondence: zambo9@catholic.ac.kr
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unless otherwise stated.size is still required, which simultaneously compromises
the benefits of SPLS and increases wound morbidity.
Therefore, it is essential to find a method for reducing the
incision size required for specimen extraction.
The pursuit of a surgical technique that involves no
external wound has led to the development of natural
orifice transluminal endoscopic surgery (NOTES) [4-6].
The fundamental concept of NOTES is to reach the
operative field through a natural orifice, such as the oral
cavity, vagina, or anal canal, thereby circumventing the
abdominal wall. Until now, most attempts at NOTES are
still in the preclinical trial stage because of technical diffi-
culties [7-9]. However, this method has inspired laparo-
scopic surgeons to borrow the basic concept of NOTES
and adapt it for laparoscopic surgery [8,10]; consequently,
hybrid laparoscopic techniques, combining laparoscopic
surgical techniques with natural orifice specimen extrac-
tion (NOSE), have been developed [11-13].is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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anus, and vagina. In colectomies, the preferred specimen
extraction site is the anus because the colectomy
procedure naturally makes way for specimen extraction
without an additional intraorgan incision [14-16]. How-
ever, the feasibility and safety of transanal NOSE in SPLS
has not yet been determined, and to the best of our
knowledge, no comparative studies have been performed
thus far. Therefore, we attempted to determine the role
of transanal specimen extraction (TASE) by comparing
its surgical outcomes with those of transumbilical speci-
men extraction (TUSE) in single-port anterior resection
(AR) or low anterior resection (LAR) for colorectal
cancer.
Methods
Study design and data collection
The prospectively collected records of patients who
underwent surgery for sigmoid colon cancer and/or
rectal cancer at Daejeon St. Mary’s Hospital, the Catholic
University of Korea, between March 2009 and March
2013, were reviewed retrospectively (Figure 1). A total ofFigure 1 Patient allocation.216 patients were enrolled at this stage. During this
period, SPLS was first attempted in colorectal cancer pa-
tients eligible for operation (i.e., those who did not have
advanced local disease [tumor size > 10 cm on preopera-
tive evaluation], unresectable metastatic lesions, an
American Society of Anesthesiologists’ physical status
classification of IV or V, or severe medical illness). His-
tory of prior laparotomy and/or the presence of acute
bowel obstruction did not preclude SPLS. Consequently,
we identified 203 patients who had undergone SPLS for
sigmoid colon cancer and/or rectal cancer. These pa-
tients had been treated by various operative methods via
a single port, including AR, LAR, abdominoperineal resec-
tion, Hartmann’s procedure, total colectomy, transanal
endoluminal laparoscopic surgery, and transabdominal
transanal resection of the sigmoid colon. Of these various
operative methods, single-port AR or LAR were indicated
when the patients were judged to have no other colonic
lesion(s) outside of the sigmoid colon and/or rectum;
when primary colonic or colorectal anastomosis after sig-
moidectomy seemed possible; or when the lesion was lo-
cated sufficiently far from the anal verge so as to preserve
Figure 2 Placement of single-ports in the umbilicus. A
Placement of homemade glove port composed of a wound
retractor (ALEX wound retractor; XS, USA), a surgical glove, and two
pipes (threaded cannulas and seals 5 mm; Applied Medical, USA).
B Placement of a commercially ready-made single port (OCTO port;
Dalim, Korea).
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mosis (EEA) stapler application. Consequently, 130 pa-
tients who had undergone single-port AR or LAR were
identified. After colectomy in single-port AR or LAR,
TUSE or TASE was performed to retrieve specimens.
TASE was selectively performed when the tumor diameter
appeared to be 5 cm or less in the preoperative evaluation
and the rectal canal could be sufficiently dilated up to
5 cm with an anal trocar. Therefore, to provide a balanced
comparison, we selected 83 patients in whom the tumor
diameter was 5 cm or less from the patient population
(n = 130), and clinical outcomes were compared between
the TUSE group (n = 68) and TASE group (n = 15). This
study was approved by the ethics committee at our insti-
tution (Institutional Review Board of Daejeon St. Mary’s
hospital, College of Medicine, the Catholic University of
Korea, IRB code: DC13RISI0079). Electronic medical
records, including radiology and pathology reports, of
all patients in each group were deliberately reviewed to
ensure accuracy. The median follow-up was 93 months
(range 13 – 149).
A complication was defined as the occurrence of any
adverse event before discharge. Postoperative complica-
tions were classified as described by Clavien and col-
leagues [17]. Delayed gastric emptying was defined as
when a nasogastric tube was required for ≥ 4 postopera-
tive days or if its reinsertion was required, or when the
patient remained intolerant to solid diet by postoperative
day 7. Urinary retention was defined as when the patient
could not pass urine within 12 h after removal of the
urinary catheter. Operative time was measured from the
time of initial skin incision to completion of wound clos-
ure, based on documentation by the anesthesiologist.
Pathological margins were determined by two pathologists
(Kim JO, Lee JU) based on formalin-fixed specimens.
Staging was based on the 6th edition of the American
Joint Committee on Cancer manual [18].
Operative technique
Under general anesthesia, the patient was placed in the
modified lithotomy position. The operating surgeon and
camera operator were positioned on the right side of the
patient, and the first assistant was positioned on the left
side. Usually, a 1.5- to 2.0-cm vertical incision was made
at the umbilicus. Initially, we designed and used a single-
port system composed of a wound retractor (ALEX wound
retractor; XS, USA), a surgical glove, 2 pipes (5-mm
threaded cannulas and seals; Applied Medical, USA),
and a trocar (Xcel 12 mm; Ethicon, USA) (Figure 2A).
Later, we replaced this system with a commercially
available ready-made single port system (OCTO port;
Dalim, Korea) that contains a 5-mm trocar and two 12-mm
trocars (Figure 2B). After mobilization of the sigmoid
colon in a medial-to-lateral fashion, we incised theretroperitoneum between the sacral promontory and
aortic bifurcation while taking care to preserve the
hypogastric nerve plexus. The inferior mesenteric artery
and vein were then identified and divided, respectively.
Next, the splenic flexure was mobilized, if necessary.
The proximal rectum was dissected free, starting from
the mesorectum. After the proximal and distal resection
margins of the tumor-bearing segment had been deter-
mined and fully mobilized, we divided the sigmoid mes-
entery with a vessel-sealing energy device (Ligasure,
Covidien, USA). Thereafter, the colon and proximal rec-
tum were tied with a nonabsorbable suture (Ethibond
EXCEL™ Polyester suture, Ethicon, USA) to isolate the
specimen and to minimize soiling.
Total mesorectal excision (TME) was performed in
all cases of rectal cancer. Before TME, we ensured the
visual field by elevating the peritoneal fold (male) or the
uterus (female) with an intracorporeal stitch. Anterior
dissection of TME widened the gap between the anterior
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posterior vaginal wall in women. In addition, posterior
and lateral dissection of TME reached the level of the
puborectalis muscle. Thereafter, the proximal and distal
ends of the lesion were completely enclosed with nylon
tape to prevent cancer dissemination. The following
steps differed according to the method of specimen
extraction (TUSE or TASE).
In patients in whom TUSE was performed, the distal
end of the tumor-bearing segment was divided with aFigure 3 Operative illustrations showing single-port laparoscopic cole
both ends of the tumor-bearing segment were bound with tape, and the
tumor-bearing segment was identified. The white arrow indicates the dir
segment. The dotted line indicates the planed resection line. B The tumo
end. C An anal trocar was entered into the pelvic cavity via the anus. D A
through the anal trocar. E The anvil was introduced into the remaining co
was retrieved through the anal trocar. H Lastly, end-to-end colorectal ana
(EEA 28 mm or 31 mm; Ethicon, USA).stapler (Endo-gastrointestinal anastomosis [GIA] Green
cartilage; Covidien, USA). The tumor-bearing segment
was subsequently delivered extracorporeally through the
umbilical wound after optimal extension of the skin inci-
sion. Extracorporeally, the proximal end of the tumor-
bearing segment was divided, and an anvil for EEA was
inserted in the remaining colon. After returning the
bowel to the abdominal cavity, end-to-end colorectal
anastomosis was performed with a transanally inserted
circular stapler (EEA 28 mm or 31 mm; Ethicon, USA).ctomy with transanal specimen extraction (TASE). After dissection,
proximal end was divided by End-GIA. A The distal end of the
ection to the rectum. The red arrow indicates the tumor-bearing
r-bearing segment was completely resected by dividing the distal
n anvil with an anchor suture was entered into the pelvic cavity
lon and was fixed by purse-string suture. F, G Thereafter, the specimen
stomosis was performed with a transanally inserted circular stapler
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proximal and distal ends of the tumor-bearing segment
were divided with a stapler (Endo-GIA Green cartilage;
Covidien, USA) and endoscissors, respectively (Figure 3).
The anal canal was then thoroughly cleansed by irriga-
tion with povidone-mixed saline solution. Next, an anal
trocar (i.e., a metal cylinder with a diameter of 3–6 cm)
was placed through the anal canal (Figure 4A). Using a
series of anal trocars, the anal canal was gradually di-
lated to prevent injury to the rectal wall and anal sphinc-
ter due to excessive pressure. To facilitate a purse string
suture, we designed an anvil with an anchoring suture
(Figure 4B). The anvil was entered into the pelvic cavity
via the anal trocar and then introduced in the remaining
colon. The anvil was put in the pelvic cavity via the open
anal canal and was inserted and fixed in the remaining
colon using intracorporeal purse string suture and Endo-
GIA stapling. The specimen was extracted smoothly
through the anal canal. Thereafter, the open distal rectalFigure 4 Prerequisites of transanal specimen extraction using
our method. A Anal trocars. They are metal cylinders with a range
of diameters (3–6 cm) that are designed for specimen extraction via
the anal canal. B An anvil with an anchor suture. The tip of the anvil
was anchored with the aim of facilitating an intracorporeal
purse-string suture.stump was sutured with an Endo-GIA stapler or by
hand-sewn sutures. Colorectal anastomosis was com-
pleted using the transanally inserted circular stapler.
Regardless of the method of specimen extraction, a
Jackson-Pratt drain was inserted through the single-port
incision site, as needed.
Postoperative care
Postoperative diet was initiated and advanced as previously
described [19]. Postoperative pain was first managed by
patient-controlled administration of intravenous fentanyl
citrate, and additional intravenous medications for pain
control were given as needed. The urinary catheter was
typically removed on postoperative day 1.
Statistical analysis
The results are presented as the mean ± standard devi-
ation and/or median (range). Continuous variables were
compared with the Mann–Whitney U-test or independent
t-test, depending on the normality of the quantitative vari-
ables. Categorical and ordinal variables were compared
with the chi-square test. Statistical analysis was performed
with SPSS version 15.0 (SPSS Inc., Chicago, IL, USA). A
p value < 0.05 was considered statistically significant.
Results
Basal characteristics and pathological comparisons
This study included 83 patients (47 men, 36 women),
comprising the TUSE group (n = 68) and TASE group
(n = 15). The median age was 66 years (range, 38–82
years), and the median body mass index was 23.2 (16.2–
30.3). Of these patients, 52 patients (62.7%) had sigmoid
colon cancer (including cancers of the rectosigmoid junc-
tion), and 31 patients (37.3%) had rectal cancer. Single-port
AR was performed in 43 patients (51.8%), and single-port
LAR was performed in 40 patients (48.2%). The baseline
demographics and patient characteristics between these
two groups were compared (Table 1). The two groups
were similar in terms of baseline characteristics, such as
age, sex, body mass index, or Charlson comorbidity index.
There were also no differences in locations of lesions and
the operative method (AR or LAR) between the two
groups.
Comparison of intraoperative and pathological variables
Table 2 shows the comparison of operative details and
pathological outcomes between the TUSE and TASE
groups. TASE resulted in a longer operative time than
did TUSE (285 ± 87 min vs. 226.0 ± 78.0 min; p = 0.011).
Thereafter, we illustrated individual operation times of
TASE cases over time, according to the operative
method (AR or LAR) (Figure 5). The sequential oper-
ation time of the TASE group appeared to decrease over
time, reflecting learning processes.
Table 1 Patient demographics and baseline characteristics
Patient characteristics Total patients (n = 83) TUSE (n = 68) TASE (n = 15) P-value
Age (years) 0.442
Median (range) 66.0 (38.0–82.0) 66.0 (38.0–82.0) 65.0 (50.0–75.0)
Mean ± SD 63.9 ± 10.3 64.3 ± 11.0 62.0 ± 8.3
Sex, n (%) 1.000
Men 47 (56.6) 38 (55.9) 6 (40.0)
Women 36 (43.4) 30 (44.1) 9 (60.0)
Body-mass index, kg/m2 (%) 0.281
Median (range) 23.2 (16.2–30.3) 23.5 (16.2–30.3) 22.0 (18.7–26.7)
Mean ± SD 23.0 ± 2.9 23.2 ± 3.0 22.3 ± 2.4
Charlson comorbidity index, n (%) 0.091
Charlson index = 0 37 (44.6) 28 (41.2) 10 (66.7)
Charlson index > 0 46 (55.4) 40 (58.8) 5 (33.3)
The location of lesion 0.151
Sigmoid colon (including the rectosigmoid junction) 52 (62.7) 40 (58.8) 12 (80.0)
Rectum 31 (37.3) 28 (41.2) 3 (20.0)
Operative method 0.259
Anterior resection 43 (51.8) 33 (48.5) 10 (66.7)
Low anterior resection 40 (48.2) 35 (51.5) 5 (33.3)
Abbreviations: SD standard deviation, TASE transanal specimen extraction, TUSE transumbilical specimen extraction.
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red cell transfusion was not significantly different be-
tween the two groups. The incidence of intraoperative
complications was also not significantly different. The
median largest tumor diameters in the TUSE and TASE
groups were 4.0 (0.3–5.0) cm and 3.0 (2.0–5.0) cm, re-
spectively (p = 0.220).
Next, pathological outcomes were compared. Several
parameters seemed to include more advanced patholo-
gies in the TUSE group than in the TASE group, such as
tumor depth (T1, T2, and T3 stages; 16.2%, 22.0%, and
61.8% in the TUSE group, respectively; 33.3%, 46.7%,
and 20.0% in the TASE group, respectively; p = 0.013)
and lymphovascular invasion (86.8% in the TUSE group
vs. 53.3% in the TASE group; p = 0.007).
The other parameters, including tumor cell differenti-
ation, lymph node metastasis, tumor stage, and perineu-
ral invasion, were comparable between the two groups.
In addition, the two groups showed similar oncologic re-
sults, such as sufficient attainment of surgical margins
and lymph nodes.
Comparison of postoperative variables
We then assessed and compared the postoperative re-
covery of gastrointestinal function, which was reflected
by the intervals to first flatus, to free oral fluids, and to
solid diet (Table 3). The two groups showed comparable
functional recovery. The frequencies of narcotic analgesics
and total analgesics administration was not significantlydifferent between the TUSE and TASE groups. The post-
operative lengths of hospital stay were also similar. Over-
all, anastomotic site leakage was the most common
postoperative complication (6/83, 7.2%), followed by de-
layed gastric emptying (n = 2), urinary retention (n = 4),
and pneumonia (n = 1). There were 4 and 1 incidences
of anastomotic site leakages in TUSE and TASE groups,
respectively. Every incidence of anastomotic site leakage
required reoperation. The extent of reoperation was var-
ied according to the severity of anastomotic site leakage.
The four cases of leakages developed in TUSE group
required irrigation with diverting ileostomy (n = 2),
primary closure with diverting ileostomy (n = 1), and
transanal closure (n = 1), respectively. The one leakage
developed in the TASE group was corrected by primary
closure with diverting ileostomy. All the patients with
leakage were recovered successfully after reoperation,
and no mortality was occurred. There was no significant
difference between TUSE and TASE groups in the over-
all postoperative complications (P = 0.196).
Thereafter, we compared wound-related complications
during the follow-up period. Whereas TUSE group ex-
hibited wound seromas (n = 4), wound infection (n = 1),
and umbilical hernia (n = 1), TASE group showed no
wound-related complications during the follow-up
period. Figure 6 shows representative illustrations of
postoperative wounds with TUSE and TASE (The pa-
tients in the images have specifically provided consent to
publish).
Table 2 Data related to operative details and tumor pathology
Characteristics Total patients (n = 83) TUSE (n = 68) TASE (n = 15) P-value
Overall operative time (min) 0.011
Median (range) 215 (95–455) 215 (95–455) 260 (155–455)
Mean ± SD 237 ± 82 226 ± 78 287 ± 87
Estimated blood loss, mL 0.884
Median (range) 200 (20–1000) 200 (20–1000) 300 (50–750)
Mean ± SD 282 ± 191 279 ± 196 287 ± 171
PRC transfused patients, n (%) 5 (6.0) 3 (4.4) 2 (13.7) 0.220
Intraoperative complications, n (%) 1.000
Vascular injury 1 (1.2) 1 (1.5) 0
Major serosal tearing 2 (2.4) 2 (2.9) 0
Total (%) 3 (3.6) 3 (4.4) 0 (0.0)
Duration of drain installation, days 0.371
Median (range) 4 (0–14) 4 (0–14) 4 (0–9)
Mean ± SD 4.1 ± 2.5 4.4 ± 2.9 3.6 ± 1.9
Tumor differentiation, n (%) 0.083
Well differentiated 3 (3.6) 1 (1.5) 2 (13.3)
Moderately differentiated 80 (96.4) 67 (98.5) 13 (86.7)
Poorly differentiated 0 (0.0) 0 (0.0) 0 (0.0)
Tumor depth (T classification), n (%) 0.013
T1 16 (19.3) 11 (16.2) 5 (33.3)
T2 22 (26.5) 15 (22.0) 7 (46.7)
T3 45 (54.2) 42 (61.8) 3 (20.0)
Lymph node metastasis, n (%) 0.331
No 81 (97.6) 67 (98.5) 14 (93.3)
Yes 2 (2.4) 1 (1.5) 1 (6.7)
Tumor stage, n (%) 0.062
I 24 (28.9) 16 (23.5) 8 (53.3)
II 19 (22.9) 17 (25.0) 2 (13.3)
III 38 (45.8) 34 (50.0) 4 (26.7)
IV 2 (2.4) 1 (1.5) 1 (6.7)
Largest tumor diameter (cm) 0.220
Median (range) 4.0 (0.2–5.0) 4.0 (0.3–5.0) 3.0 (2.0–5.0)
Mean ± SD 3.3 ± 1.4 3.4 ± 1.3 3.0 ± 1.8
Lymph nodes in resected specimen 0.785
Median (range) 17.0 (0–49) 17.0 (0–49) 18 (6–41)
Mean ± SD 17.1 ± 9.3 17.0 ± 9.4 17.7 ± 9.6
Proximal margin (cm) 0.744
Median (range) 7.0 (3.0–105.0) 6.0 (3–105) 8.0 (4.0–20.0)
Mean ± SD 10.0 ± 12.2 9.4 ± 13.2 9.5 ± 4.6
Distal margin (cm) 0.359
Median (range) 5.0 (2.0–37.0) 5.4 (3–37) 5.0 (4.0–12.5)
Mean ± SD 7.0 ± 5.0 7.2 ± 5.2 6.2 ± 2.7
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Table 2 Data related to operative details and tumor pathology (Continued)
Perineural invasion, n (%) 0.749
No 61 (73.5) 49 (72.1) 12 (80.0)
Yes 22 (26.5) 19 (27.9) 3 (20.0)
Lymphovascular invasion, n (%) 0.007
No 16 (19.3) 9 (13.2) 7 (46.7)
Yes 67 (80.7) 59 (86.8) 8 (53.3)
Abbreviations: PRC packed red blood cells, SD standard deviation, TASE transanal specimen extraction, TUSE transumbilical specimen extraction.
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In this study, we attempted to determine the utility of
TASE by comparing it with TUSE. The process of TASE
prolonged the overall operation time because of the add-
itional detailed procedures. However, the TASE group
showed similar results as the TUSE group in other
parameters, such as the incidence of intraoperative and
postoperative complications, postoperative gastrointes-
tinal functional recovery, the frequency of postoperative
analgesics usage, and the length of hospital stay; this re-
flects the safety and feasibility of the procedure. Notably,
though it did not reach statistical significance, wound-
related complications were lower in TASE than TUSE
(0.0% vs. 8.8%, P = 0.586). Although the sample size was
too small for definitive conclusions, these preliminary
results suggest the safety and feasibility of TASE.
The NOSE technique involves specimen extraction
through a natural orifice, such as the anus or vagina.
There are several benefits of NOSE. Most of all, NOSE
can improve cosmesis dramatically by negating wound
extension for specimen extraction. In addition, NOSE
can reduce wound morbidities, such as wound infection,
injury to the vessels and nerves of the abdominal wall,
and incisional hernia [1-3]. Moreover, NOSE theoretic-
ally reduces postoperative somatic pain at the incision
site. Postoperative pain after laparoscopic surgery isFigure 5 The changes in the operative times of the TASE (transanal sp
(A) and low anterior resection (B).determined by a combination of numerous factors,
including wound size, distension-induced neuropraxia of
the phrenic nerves, residual intra-abdominal gas after
laparoscopy, the humidity and volume of the insufflated
gas, anesthetic drugs, and sociocultural and individual
factors [20]. Of these, wound size constitutes a substan-
tial portion. In this study, the TASE group required
lower doses of both narcotic analgesics and total analge-
sics, though the difference did not reach statistical
significance. Further studies with an adequately larger
patient population are necessary to determine the effects
of TASE on postoperative pain.
The natural orifices commonly used for specimen
extraction during colectomies are the anus (TASE) and
vagina (TVSE, transvaginal specimen extraction). TASE
has several advantages over TVSE, especially in colorec-
tal surgery [12]; it can be used regardless of sex, does
not require additional intraorgan incision, and is tech-
nically more feasible. In contrast, the process of TVSE is
more complicated due to the anatomy of Douglas’s
pouch. It was reported that protective ileostomy was
required more frequently in TVSE than in TASE because
of accidental intraoperative damage to the sigmoid colon
and rectum [12].
There are several qualifications for the ideal method of
specimen extraction. First, it should ensure patient safetyecimen extraction) group following single-port anterior resection






Duration prior to first flatus, day(s) 0.298
Median (range) 2.0 (1.0–5.0) 2.0 (1.0–4.0)
Mean ± SD 1.9 ± 1.1 2.2 ± 1.0
Durations prior to free oral fluids 0.291
Median (range) 1.0 (1.0–10.0) 3.0 (1.0–10.0)
Mean ± SD 2.2 ± 1.8 2.8 ± 2.4
Duration prior to solid diet, day(s) 0.403
Median (range) 2.0 (1–22) 4.0 (1–14)
Mean ± SD 3.4 ± 3.2 4.2 ± 3.2
Frequency of narcotic analgesics 0.297
Median (range) 1.0 (0.0–25.0) 1.0 (0.0–11.0)
Mean ± SD 3.0 ± 4.6 2.1 ± 3.1
Frequency of total analgesics 0.448
Median (range) 2.0 (0.0–40.0) 2.0 (0.0–11.0)




Median (range) 7.0 (4.0–55.0) 6 (4–16)
Mean ± SD 10.3 ± 9.6 7.5 ± 3.6
Overall postoperative
complications, %
14.7 (10/68) 20.0 (3/15) 0.196
Grade I
Delayed gastric emptying 0 1
Urinary retention 1 0
Grade II
Urinary retention 2 1
Delayed gastric emptying 1 0
Pneumonia 1 0
Grade III
Anastomotic site leakage 5 1
Wound-related complications
during FU period, %
8.8 (6/68) 0.0 (0/15) 0.586
Seroma 4 0
Wound infection 1 0
Umbilical hernia 1 0
Mortality, % 0 0 1.00
Abbreviations: FU follow-up, SD standard deviation, TASE transanal specimen
extraction, TUSE transumbilical specimen extraction.
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operative period. In addition, it should not be so tech-
nically difficult as to significantly prolong the operation
time. Finally, the process of specimen extraction should
not offset the advantages of minimally invasive surgery.
Taken together, TASE may be considered a preferredmethod of specimen extraction after single-port AR or
LAR. TASE resulted in equivalent surgical outcomes as
TUSE in terms of postoperative complications, while leav-
ing a NOTES-like scar (≤ 2 cm). The major demerit of
TASE was a longer operation time; however, considering
the benefits of TASE and the trends in shortening oper-
ation times, this demerit may be easily overcome.
In our study, there was a lengthening of operation
time in TASE group (260 min vs. 215 min, P < 0.011).
So far, there have been no reports comparing the oper-
ation time between TUSE and TASE in SPLS. Mean-
time, applications of TASE into the conventional
laparoscopic surgery have been sporadically reported.
Wolthuis et al. [16] reported in a systematic analysis
that TASE did not lengthen the operation time in the
procedures involving left-sided laparoscopic colectomy
compared with TUSE. Fuchs et al.[8] also concluded
after the earlier experience of TASE in the laparoscopic
surgery that the application of TASE to laparoscopic
surgery was quite easy and is not a major problem for
an experienced laparoscopic surgeon, indicating that
TASE procedure does not require a long learning curve
or the acquisition of new, specialized skills. Interest-
ingly, in a paper comparing TUSE and TVSE, TVSE
required longer operation time, possibly due to the ne-
cessity of intracorporeal suturing and anastomosis took
longer [21]. Further study with a larger population is
warranted to investigate the effects of TASE in the
overall operation time in SPLS.
A drawback to TASE is its limited application; it can be
applied to the patients with a small tumor, i.e. a tumor
diameter of 5 cm or less in this study. We have designed
anal trocars in various sizes up to 6 cm (3-, 4-, 5-, and
6-cm) for the restoration of rectal sphincter muscle
tone. The median tumor diameter in the TASE group
was 3.0 cm (2.0–5.0 cm) in this study. However, we
think as surveillance system enables the early detection
of colorectal cancer, the inclusion of patients who would
benefit from TASE would be wider.
In our series, we did not observe fecal incontinence or
any complications related to anorectal function. Exces-
sive pressure during TASE can induce fecal incontin-
ence, possibly due to the loss of anal sphincter muscle
tone [12]. Therefore, in every surgery, we attempted to
avoid excessive rectal dilatation. We gently retrieved the
specimen by way of the metallic anal trocar made of
stainless steel, which gradually dilated the anus and rec-
tal wall within very limited time span. Multiple reports
on the anorectal function after trananal endoscopic
microsurgery (TEM) has shown that TEM, even repeated
TEMs, does not affect anal sphincter pressure, rectoanal
reflexes, rectal sensation or compliance [22-26]. Thus we
think TASE is safe, in terms of anorectal function, in
patients with a tumor diameter of ≤5 cm.
Figure 6 Representative illustrations of postoperative wounds. A Postoperative wound following transumbilical specimen extraction (TUSE).
B Postoperative wound following transanal specimen extraction (TASE).
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http://www.biomedcentral.com/1471-2482/15/10The limitations of this study are those common to all
database research. As a retrospective review of prospect-
ively collective data, our results should be confirmed by
a prospective trial. Next, the limitations of this pilot
study also include the small patient population, espe-
cially TASE patients (n = 15). In addition, TUSE and
TASE groups seemed to be not completely balanced;
TUSE patients showed higher incidences of T3 tumor
(61.8% vs. 20.0%, P = 0.013) and lymphovascular invasion
(86.8% vs. 53.3%, P = 0.007), suggesting advanced histology.
Conclusion
This pilot study shows that with the exception of oper-
ation time, surgical outcomes of TASE were comparable
to those of TUSE. Even though TASE prolonged oper-
ation time, it appeared to decrease over time, suggesting
an adequate learning curve. In addition, TASE procedure
did not affect anorectal function. In the SPLS, extension
of a single incision for the purpose of specimen extrac-
tion can undermine the merits of SPLS either by hurting
cosmesis or by increasing wound morbidity, such as um-
bilical hernia. Though the establishment of the safety
and feasibility of TASE requires further study, the imple-
ment of TASE in SPLS is expected to provide one way
of reducing wound-related complications in patients
with a tumor diameter of ≤5 cm.
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